Clinical Trial Update: An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)

View source ↗

Summary

Observational study update of OZURDEX (dexamethasone intravitreal implant) in diabetic macular edema; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Allergan | Conditions: Macular Edema | Status: COMPLETED